Okoromah C N, Lesi F E A
Paediatrics and Child Health, College of Medicine of the University of Lagos, Idi-Araba, Lagos, Lagos, Nigeria.
Cochrane Database Syst Rev. 2004;2004(1):CD003954. doi: 10.1002/14651858.CD003954.pub2.
Clinical management of the muscle spasms and rigidity of tetanus poses a difficult therapeutic problem to physicians everywhere, especially in resource poor countries. There are wide variations in therapeutic regimens commonly used in clinical practice due to uncertainties about effectiveness of conventional drugs. Diazepam compared to other drugs (eg phenobarbitone and chlorpromazine) may have advantages because of combined anticonvulsant, muscle relaxant, sedative and anxiolytic effects.
To compare diazepam to other drugs in treating the muscle spasms and rigidity of tetanus in children and adults.
We searched the Cochrane Neonatal Group trials register (October 2003), Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 3, 2003), MEDLINE (1966 to October 2003), EMBASE (1980 to October 2003), LILACS (2003), CINAHL (October 2003), Science Citation Index, African Index Medicus, conference abstracts and reference lists of articles. We contacted researchers, experts and organizations working in the field and used personal communication.
Randomized and quasi-randomized controlled trials.
We independently identified eligible trials, assessed trial methodological quality and extracted data.
Two studies met the inclusion criteria. Method of generation of allocation sequence, concealment of allocation and blinding were unclear in both studies. A total of 134 children were allocated to three treatment groups comprising diazepam alone, phenobarbitone and chlorpromazine, or phenobarbitone and chlorpromazine and diazepam.Meta-analysis of in-hospital deaths indicates that children treated with diazepam alone had a better chance of survival than those treated with combination of phenobarbitone and chlorpromazine (Relative Risk for death 0.36; 95% confidence interval 0.15 to 0.86; Risk Difference -0.22; 95% CI -0.38 to -0.06). Giving diazepam alone, or supplementing conventional anticonvulsants (phenobarbitone and chlorpromazine) with diazepam, was reported in one study to be associated with a statistically significantly milder clinical course and shorter duration of hospitalization.
REVIEWER'S CONCLUSIONS: Although there is evidence that diazepam alone compared with combination of phenobarbitone and chlorpromazine is more effective in treating tetanus, the small size, methodological limitations and lack of data on drug safety from available trials preclude definite conclusions to support change in current clinical practice. The application of the present evidence should be moderated by local needs and circumstances, pending the availability of more evidence. We recommend a large multicenter, randomized controlled trial which compares diazepam alone with combinations of other drugs (excluding diazepam).
破伤风所致肌肉痉挛和强直的临床管理给各地医生带来了棘手的治疗难题,在资源匮乏国家尤为如此。由于传统药物疗效存在不确定性,临床实践中常用的治疗方案差异很大。与其他药物(如苯巴比妥和氯丙嗪)相比,地西泮可能具有优势,因为它具有抗惊厥、肌肉松弛、镇静和抗焦虑的综合作用。
比较地西泮与其他药物治疗儿童和成人破伤风所致肌肉痉挛和强直的效果。
我们检索了Cochrane新生儿组试验注册库(2003年10月)、Cochrane对照试验中央注册库(《Cochrane图书馆》,2003年第3期)、MEDLINE(1966年至2003年10月)、EMBASE(1980年至2003年10月)、LILACS(2003年)、CINAHL(2003年10月)、科学引文索引、非洲医学索引、会议摘要以及文章的参考文献列表。我们联系了该领域的研究人员、专家和组织,并采用了个人交流的方式。
随机和半随机对照试验。
我们独立识别符合条件的试验,评估试验方法学质量并提取数据。
两项研究符合纳入标准。两项研究中分配序列的产生方法、分配隐藏和盲法均不明确。共有134名儿童被分配到三个治疗组,分别为单独使用地西泮、苯巴比妥和氯丙嗪,或苯巴比妥、氯丙嗪和地西泮联合使用。住院死亡的Meta分析表明,单独使用地西泮治疗的儿童比使用苯巴比妥和氯丙嗪联合治疗的儿童存活机会更大(死亡相对风险0.36;95%置信区间0.15至0.86;风险差值-0.22;95%置信区间-0.38至-0.06)。一项研究报告称,单独使用地西泮或用地西泮补充传统抗惊厥药(苯巴比妥和氯丙嗪)与临床病程统计学上显著较轻和住院时间较短相关。
尽管有证据表明单独使用地西泮比苯巴比妥和氯丙嗪联合使用在治疗破伤风方面更有效,但现有试验规模小、方法学存在局限性且缺乏药物安全性数据,无法得出明确结论来支持改变当前临床实践。在有更多证据之前,应根据当地需求和情况适度应用现有证据。我们建议开展一项大型多中心随机对照试验,比较单独使用地西泮与其他药物(不包括地西泮)联合使用的效果。